Clinical Trial Designs for Immunogenicity Assessments
Time: 4:30 pm
day: Day One
Details:
- Incorporate Immunogenic Adverse Events assessment endpoints in clinical trial protocols and statistical analyses plans
- Implementing robust systems for collection and medical evaluation of Immunogenic Adverse Events occurring during clinical trials
- Identifying clinically significant Immunogenic Adverse Events for participants with and without ADA
